DSM Integrated Annual Report 2021

11 Other financial assets

 

 

Loans associates and joint ventures

 

Other participating interests

 

Other receivables

 

Other

 

Total

 

 

 

 

 

 

 

 

 

 

 

Balance at 1 January 2020

 

3

 

150

 

103

 

7

 

263

 

 

 

 

 

 

 

 

 

 

 

Changes:

 

 

 

 

 

 

 

 

 

 

- Charged to the income statement

 

-

 

-

 

-

 

(2)

 

(2)

- Acquisitions

 

-

 

-

 

-

 

4

 

4

- Disposals

 

-

 

(47)

 

-

 

-

 

(47)

- Capital payments

 

-

 

11

 

-

 

-

 

11

- Loans granted/prepayments

 

1

 

-

 

8

 

-

 

9

- Repayments

 

-

 

-

 

(5)

 

4

 

(1)

- Exchange differences

 

-

 

-

 

(10)

 

-

 

(10)

- Transfers

 

-

 

-

 

(7)

 

(4)

 

(11)

- Changes in fair value

 

-

 

106

 

-

 

-

 

106

- Other

 

-

 

(1)

 

(6)

 

-

 

(7)

Balance at 31 December 2020

 

4

 

219

 

83

 

9

 

315

 

 

 

 

 

 

 

 

 

 

 

Changes:

 

 

 

 

 

 

 

 

 

 

- Charged to the income statement

 

-

 

-

 

(14)

 

(2)

 

(16)

- Disposals

 

-

 

(123)

 

-

 

-

 

(123)

- Capital payments

 

-

 

35

 

-

 

-

 

35

- Loans granted/prepayments

 

-

 

-

 

10

 

-

 

10

- Repayments/(receipts)

 

-

 

-

 

(31)

 

1

 

(30)

- Exchange differences

 

-

 

-

 

3

 

-

 

3

- Transfers

 

(3)

 

14

 

(20)

 

(4)

 

(13)

- Changes in fair value

 

-

 

46

 

-

 

-

 

46

Balance at 31 December 2021

 

1

 

191

 

31

 

4

 

227

‘Disposals’ includes the divestment of part of DSM’s minority share in Amyris, Inc. (€105 million) and other participating interests held by DSM Venturing (€18 million).

‘Changes in fair value’ consists mainly of the value increase of our minority share in Amyris, Inc. (€68 million) and the fair value adjustment of DSM’s share in BCPE Max Dutch JVCo B.V. (€36 million). These changes are posted to the Fair value reserve in Other comprehensive income.